UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000001191 |
|---|---|
| Receipt number | R000001401 |
| Scientific Title | A phase II study of the remission induction and maintenance therapy by rituximab for rituximab naive low grade B cell lymphoma. |
| Date of disclosure of the study information | 2008/06/20 |
| Last modified on | 2016/06/16 11:39:07 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2008/06/16 13:36:22 | ||
| 2 | Update | 2012/01/19 13:21:57 | Name of person sending information Organization Division name Address Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 3 | Update | 2012/01/19 13:22:55 | Recruitment status |
|
| 4 | Update | 2015/12/17 07:40:29 | Email |
|
| 5 | Update | 2016/06/16 11:39:07 | Name of primary person or sponsor Organization Category of Funding Organization |
